EUVIMEDEUVIMED entdecken
Open Access

Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response

Daisuke Araki, Vicky Chen, Neelam Redekar, Christi Salisbury-Ruf, Yan Luo, Poching Liu, Yuesheng Li, Richard H Smith, Pradeep Dagur, Christian Combs, Andre Larochelle

Cell Stem Cell · 2025-01 · 32 (1) · 53-70.e8

DOI: 10.1016/j.stem.2024.10.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2025-01. Verfasst von Daisuke Araki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892…. Hauptthemen laut MEDLINE: Granulocyte Colony-Stimulating Factor, Tumor Suppressor Protein p53, Gene Editing, Hematopoietic Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Heart Lung and Blood Institute Division of Intramural Research, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte Colony-Stimulating FactorTumor Suppressor Protein p53Gene EditingHematopoietic Stem CellsHematopoietic Stem Cell TransplantationDNA DamageHumansAnimalsMiceCRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPR-Cas9DNA damage responseDNA double-stranded breaksG-CSFapoptosiscell-cycle arrestgene editinggranulocyte colony stimulating factorhematopoietic stem and progenitor cellsp53 pathway

Substanzen

Granulocyte Colony-Stimulating FactorTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
  • Integrated Data Science Services (IDSS), National Institutes of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA.
  • DNA Sequencing and Genomics Core Facility, NHLBI, NIH, Bethesda, MD 20892, USA.
  • Flow Cytometry Core Facility, NHLBI, NIH, Bethesda, MD 20892, USA.
  • Light Microscopy Core Facility, NHLBI, NIH, Bethesda, MD 20892, USA.
  • Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA. Electronic address: larochea@nhlbi.nih.gov.

Förderung

  • Intramural NIH HHS
  • National Heart Lung and Blood Institute Division of Intramural Research
  • National Institutes of Health
  • National Heart and Lung Institute
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Araki, D., Chen, V., Redekar, N., Salisbury-Ruf, C., Luo, Y., Liu, P., Li, Y., Smith, R. H., Dagur, P., Combs, C., & Larochelle, A. (2025). Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response. Cell Stem Cell, 32(1), 53-70.e8. https://doi.org/10.1016/j.stem.2024.10.013

Vancouver

Araki D, Chen V, Redekar N, Salisbury-Ruf C, Luo Y, Liu P, et al. Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response. Cell Stem Cell. 2025;32(1):53-70.e8. doi:10.1016/j.stem.2024.10.013

BibTeX
@article{Araki2025,
  author = {Araki, Daisuke and Chen, Vicky and Redekar, Neelam and Salisbury-Ruf, Christi and Luo, Yan and Liu, Poching and Li, Yuesheng and Smith, Richard H and Dagur, Pradeep and Combs, Christian and Larochelle, Andre},
  title = {Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response},
  journal = {Cell Stem Cell},
  year = {2025},
  volume = {32},
  number = {1},
  pages = {53--70.e8},
  doi = {10.1016/j.stem.2024.10.013}
}
Kostenlos starten →